- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Metformin with osteogenic and anti inflammatory properties Shows Promise in Periodontal Therapy: Study

Metformin demonstrates osteogenic and anti-inflammatory properties, suggesting potential as an adjunct in periodontal therapy. However, heterogeneous studies, short follow-up, and lack of meta-analysis limit conclusions, highlighting the need for robust long-term research.
A study was done to improve clinical and radiographic results in patients with periodontitis, this systematic review assessed the efficacy of metformin (MF) as an adjuvant to surgical and nonsurgical periodontal therapy. Patients with periodontitis (P), Metformin as an adjuvant (I), periodontal therapy alone, or placebo (C), and outcomes such as bone regeneration (O), clinical attachment level (CAL), and probing depth (PD), were evaluated with the PICO framework. Between June 15 and July 1, 2025, we searched for in vitro, in vivo, and randomized controlled trials (RCTs) published between June 2015 and June 2025 in PubMed, Google Scholar, ScienceDirect, and Semantic Scholar. Data were narratively synthesized according to MF concentration (0.5–1.5%), outcome measures, and patient type. The Cochrane tools SYRCLE and QUIN were used to assess risk of bias for RCTs, animal studies, and in vitro studies.
The analysis included 15 RCTs, 10 in vitro studies, and 8 in vivo studies among 4005 identified records. The most commonly used formulation was local Metformin gel. Follow-up times ranged from 1 to 9 months. Metformin, in contrast to scaling and root planing or placebo, produced vertical bone fill as high as 26.8%, a CAL gain of 1.5–2.7 mm, and a PD decrease of 1.5–3.4 mm. Experimental investigations had moderate risk of bias, whereas RCTs had low risk of bias.
Metformin's osteogenic and anti-inflammatory qualities make it a promising adjuvant in periodontal therapy. However, the need for additional long-term research was highlighted by the study heterogeneity, limited follow-up periods, and a lack of meta-analysis.
Reference:
Muhammad K.H. Uddin, Aanya Naseem, Syeda M. Aziz, Saba Rafiq, Mehak A. Sattar, Muhammad S. Zafar, Bilquees Saba, Humaira Hassan, Efficacy of metformin as an adjunct in periodontitis: A systematic analysis, Journal of Taibah University Medical Sciences,
Volume 21, Issue 2, 2026, Pages 332-348, ISSN 1658-3612, https://doi.org/10.1016/j.jtumed.2026.03.007.
(https://www.sciencedirect.com/science/article/pii/S1658361226000338)
Keywords:
Adjunctive therapy, Bone regeneration, Metformin, Periodontitis, RCTs, Muhammad K.H. Uddin, Aanya Naseem, Syeda M. Aziz, Saba Rafiq, Mehak A. Sattar, Muhammad S
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

